OMass Revenue and Competitors

Oxford,

Location

#3916

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • OMass's estimated annual revenue is currently $14.6M per year.(i)
  • OMass's estimated revenue per employee is $155,000

Employee Data

  • OMass has 94 Employees.(i)
  • OMass grew their employee count by 16% last year.

OMass's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
SVP Finance and OperationsReveal Email/Phone
4
SVP Clinical DevelopmentReveal Email/Phone
5
VP ImmunologyReveal Email/Phone
6
VP Medicinal ChemistryReveal Email/Phone
7
VP, NonclinicalReveal Email/Phone
8
VP, PharmacologyReveal Email/Phone
9
VP, Platforms and FounderReveal Email/Phone
10
Associate Director - Finance & OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is OMass?

OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Sciences Innovation.

keywords:N/A

N/A

Total Funding

94

Number of Employees

$14.6M

Revenue (est)

16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OMass News

2022-04-17 - Syncona : OMass CEO Ros Deegan Named as a 2022 In Vivo Rising Leader

Oxford, United Kingdom - 19 April 2022 - OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines...

2022-04-06 - Publication in Nature by OMass Founder, Professor Dame ...

Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by...

2022-03-22 - OMass Establishes Scientific Advisory Board of Leading ...

Oxford, United Kingdom – 7 March 2022 – OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines against...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.7M9553%N/A
#2
N/A9523%N/A
#3
$7.5M965%N/A
#4
$15.2M98-26%N/A
#5
$17.6M989%N/A